Session 3 Novel Methods of Exposure Assessment – 1:00-2:00 How can we identify exposures using novel techniques? Protein Adducts as Exposure Biomarkers: The State of William Funk, Northwestern University the Science Jon Sobus, U.S. Environmental Non-targeted analysis of archived specimens for Protection Agency discovering past exposures Chirag Patel, Harvard University Challenges and Opportunities in Developing a Search Engine for Exposures Associated with Disease Risk 2:00-2:45 Panel and Audience Discussion: How might these techniques be Moderated by: useful to DoD? Joyce Tsuji, Exponent Panelists: Session speakers and Ben Blount, Centers for Disease Control and Prevention 2:45-3:00 BREAK 3:00-4:20 How can novel techniques help refine exposure questions of interest? Deployment-associated exposure surveillance with Dean Jones, Emory University high-resolution metabolomics Multi-platform mass spectrometry methods to assess Doug Walker, Emory University toxicant exposure and biological response State of the science in dried blood spots Jeff Freeman, Johns Hopkins University Using pooled samples to refine questions of interest Lesa Aylward, Summit Toxicology 4:20-5:00 Audience Discussion: How might these techniques be useful to Moderated by: DoD? Cerhan, Mayo Clinic End of Day 1 FRIDAY | June 15, 2018 | Room 125 Session 4 Biomarker Interpretation and Interaction with Disease States – 9:00-9:05 Welcome, Recap of Day 1 Lesa Aylward, Summit Toxicology 9:05-10:05 Biomonitoring considerations critical to generate Antonia Calafat, Centers for Disease Control and interpret exposure data using archived samples and Prevention How to assess and interpret the biomonitoring data Judy LaKind, LaKind Associates once you have it Effect of individual-specific conditions on Joyce Tsuji, Exponent biomonitoring results: metals as case examples 10:05-11:05 Panel and Audience Discussion: What important factors Moderated by: should DoD consider when generating and interpreting Ben Blount, Centers for Disease Control and biomonitoring results? Prevention Panelists: Session speakers 11:05-11:15 BREAK
Session 3 – Novel Methods of Exposure Assessment 1:00-2:00 How can we identify exposures using novel techniques? Protein Adducts as Exposure Biomarkers: The State of the Science Non-targeted analysis of archived specimens for discovering past exposures Challenges and Opportunities in Developing a Search Engine for Exposures Associated with Disease Risk William Funk, Northwestern University Jon Sobus, U.S. Environmental Protection Agency Chirag Patel, Harvard University 2:00-2:45 Panel and Audience Discussion: How might these techniques be useful to DoD? Panelists: Session speakers and Ben Blount, Centers for Disease Control and Prevention Moderated by: Joyce Tsuji, Exponent 2:45-3:00 BREAK 3:00-4:20 How can novel techniques help refine exposure questions of interest? Deployment-associated exposure surveillance with high-resolution metabolomics Multi-platform mass spectrometry methods to assess toxicant exposure and biological response State of the science in dried blood spots Using pooled samples to refine questions of interest Dean Jones, Emory University Doug Walker, Emory University Jeff Freeman, Johns Hopkins University Lesa Aylward, Summit Toxicology 4:20-5:00 Audience Discussion: How might these techniques be useful to DoD? Moderated by: Cerhan, Mayo Clinic End of Day 1 FRIDAY | June 15, 2018 | Room 125 Session 4 – Biomarker Interpretation and Interaction with Disease States 9:00-9:05 Welcome, Recap of Day 1 Lesa Aylward, Summit Toxicology 9:05-10:05 Biomonitoring considerations critical to generate and interpret exposure data using archived samples How to assess and interpret the biomonitoring data once you have it Effect of individual-specific conditions on biomonitoring results: metals as case examples Antonia Calafat, Centers for Disease Control and Prevention Judy LaKind, LaKind Associates Joyce Tsuji, Exponent 10:05-11:05 Panel and Audience Discussion: What important factors should DoD consider when generating and interpreting biomonitoring results? Panelists: Session speakers Moderated by: Ben Blount, Centers for Disease Control and Prevention 11:05-11:15 BREAK
best-6-5-18.docx